返回排名列表

CorVel Corp. (CRVL)

被高估
Financial ServicesInsurance BrokersUnited States

基本面

64

价格

$75.69

市值

$3.77B

第一部分 · 这家公司值多少

概览

CorVel is an independent, nationwide US provider of medical cost containment and managed care services for payors of workers' compensation benefits, auto insurance claims and group health benefits. Its customers are insurance carriers, third-party administrators (TPAs), government entities, municipalities, state funds and self-insured employers, served through a network of local branch offices backed by national teams. The company reviews and reprices medical bills, manages provider networks, and manages injured-worker claims from the first notice of injury to return to work, applying proprietary technology — including an AI bill-review engine the filing says contains over 100 million rules, and the CareMC online portal. Services are sold as a fully integrated claims-management program, as standalone modules, or as add-ons plugged into a client's existing workflow. CorVel was incorporated in Delaware in 1987 and is headquartered in Fort Worth, Texas; virtually all operating revenue is generated in the United States.

盈利方式

CorVel is paid in fees for services, not for bearing insurance risk: it is an outsourcer for payors, so it earns fees per bill reviewed, per claim administered and per case managed, plus fees for discrete services such as independent medical examinations, pharmacy, imaging, physical therapy, durable medical equipment and translation/transportation through its CareIQ directed-care network. Network solutions revenue is tied to the volume of medical bills processed and to the savings produced per bill — the filing attributes the fiscal 2026 increase to existing customers expanding their use of enhanced bill review programs, which raised revenue per bill. Patient management revenue is tied to claim referrals and to TPA and related claims-administration work, so it follows the number of new claims. Revenue is therefore essentially recurring transactional volume under multi-year customer relationships rather than licence or subscription income.

分部营收

Patient management services62.2%

Claims administration (TPA), case management, 24/7 nurse triage, utilization management, vocational rehabilitation and life care planning for workers' compensation and property & casualty payors — sold standalone or bundled with cost containment. Revenue was $596 million in fiscal 2026 against total revenue of $959 million.

Network solutions services37.8%

Medical bill review and repricing, PPO network management, fee-schedule and out-of-network review, pharmacy, Medicare solutions, independent medical examinations and the CareIQ directed-care network (imaging, physical therapy, durable medical equipment, translation and transportation). Revenue was $362 million in fiscal 2026 against total revenue of $959 million.

护城河

转换成本 · 狭窄

CorVel's advantage is narrow and partly self-limiting. Once a payor runs its claims through CareMC and CorVel's bill-review engine, the workflow, the historical claim data and the branch staff embedded with the client's adjusters are costly to unwind, and an integrated end-to-end programme is stickier than a standalone module. The bill-review engine itself — described in the filing as carrying over 100 million rules — and a nationwide branch network are hard for a local vendor to replicate. But the filing itself is blunt about the limits: the markets for network services and patient management are described as fragmented and competitive, with price competition in a flat-to-declining workers' compensation market, competitors that have more resources, and customers who can simply bring the work in-house. A moat that a large carrier can bypass by insourcing is not a wide one.

需求驱动因素

中度周期性

Workers' compensation is a federally mandated, state-legislated programme: employers must fund medical costs and lost wages for work-related injuries whatever the economy is doing, so the underlying need for claims administration and bill review does not disappear in a downturn. What does move is volume. Demand follows employment, hours worked and the mix of the labour force: the filing notes the Bureau of Labor Statistics counted 2.34 million occupational injuries in 2024 against 2.69 million in 2019, that the count has not returned to pre-pandemic levels, and that a less labour-intensive, more service-oriented economy means fewer work-related injuries over time. Medical cost inflation and state fee-schedule complexity work the other way, since they are what makes cost containment worth buying. CorVel adds that it offset falling claim counts between 2020 and 2024 by gaining market share, which is a company-specific offset rather than a market tailwind.

主要风险

  • Price competition in a flat-to-declining workers' compensation market — The company lists the decline in manufacturing employment, the decline in workers' compensation claims, the decline in healthcare expenditures and considerable price competition among the factors that create an environment where revenue and margin growth is harder to attain and less certain than historically experienced. It states there can be no assurance that future growth will be at or near historical levels.
  • Customers can bring the work in-house — The filing warns that potential customers may decide to perform services internally rather than outsource, that several large workers' compensation carriers already offer managed care services in-house, and that industry consolidation may push carriers to perform more of these services themselves. If payors reduce the amount of work they outsource, results of operations would be materially adversely affected.
  • Decline in patient management referrals — The company discloses that it has in some years experienced a general decline in referrals for patient management services, citing increased regional and local competition, possible reductions by insurers in the types of services they buy, office closures and consolidation of patient management operations, and employee turnover including management personnel. It states that if these conditions continue, patient management revenues could decrease.
  • Falling injury and claim volumes — The company notes that as the labour market has become less labour intensive and more service oriented, work-related injuries have been declining and employers are more proactive in preventing them. If declines in workers' compensation costs occur across many states and persist over the long term, the filing says the impact on the business would be material and adverse.
  • Loss or non-renewal of customer contracts — Among the disclosed risk factors is that if several customers terminate, or do not renew or extend, their contracts, results could be materially and adversely affected — a real exposure for a fee-per-transaction outsourcer whose revenue sits inside renewable service agreements.
  • Cybersecurity incidents and handling of sensitive health data — The filing warns that cybersecurity attacks or data-handling incidents could remain undetected for some period of time, causing significant harm to its systems and leading to unauthorised access to data, and that any such incident, whether caused by employees or third parties, could damage customer relationships and restrict the company's ability to operate, with a material adverse effect on the business and on its reputation.
  • Technology obsolescence, AI disruption and AI regulation — The company has made substantial investments in software critical to core operations; it warns these may require costly maintenance or replacement, that disruptive technologies could change claims-management processes and the volume and pricing of its products, and that new entrants using artificial intelligence and other technology could alter business models. It adds that failure to comply with applicable laws or regulations on artificial intelligence could expose it to investigations, enforcement actions, lawsuits, fines or other penalties.
  • Acquisition and integration risk — Growth partly depends on acquisitions and relationships in the workers' compensation managed care industry. The filing lists the attached risks: one-time charges, substantial debt or liabilities, goodwill and intangible write-downs, difficulty assimilating businesses, technologies and personnel, disruption and distraction of management, acquired businesses failing to generate enough revenue to offset their cost, and dilution if equity is issued.

客户集中度

The filing states that no single customer accounted for 10% or more of revenue in fiscal years 2026, 2025 or 2024, and does not disclose a combined share for the largest customers, so no number can be given. It describes the customer base as diverse — insurers, TPAs, self-administered employers, government agencies, municipalities and state funds. One qualification: two customers each accounted for 10% or more of accounts receivable as of March 31, 2026 and 2025, so billing exposure is more concentrated than revenue. Concentration also exists in another form the filing flags among its risks: the loss of several customers at once, since many claims-management decisions sit with local claims offices of national or regional insurers.

看多理由

Buyers argue that CorVel sells a service its customers buy precisely because costs are rising: medical inflation and the state-by-state complexity of workers' compensation are what make outsourced bill review and claims management worth paying for. They point to the fiscal 2026 numbers — revenue of $959 million against $896 million the year before, with network solutions growing to $362 million from $314 million — and note that the growth came from existing customers expanding their use of enhanced bill review, which raised revenue per bill: the same claims processed at a higher fee, not just more claims. They argue that a fee-for-service outsourcer carries no underwriting risk, that an installed CareMC workflow and an AI rules engine the filing says holds over 100 million rules are awkward for a payor to replace, and that management has funded large buybacks — $56.2 million spent on 782,744 shares in fiscal 2026 — out of operating cash flow rather than debt. They also read the company's own statement that it offset falling injury counts from 2020 to 2024 with market share gains as evidence it can grow in a shrinking market.

看空理由

Sellers fear that the end market is shrinking underneath the company. CorVel's own risk factors describe a flat-to-declining workers' compensation market with considerable price competition, falling manufacturing employment, and an injury count that in 2024 was still below 2019 — growth that has to come from taking share is harder and less certain than growth from a rising market, and the filing says so explicitly. They point out that the largest customers are the ones best placed to stop being customers: several large carriers already perform managed care in-house, industry consolidation may push more of them to do so, and the filing warns that if payors reduce what they outsource the effect would be materially adverse. They note that patient management, the larger of the two service lines at $596 million in fiscal 2026, grew only 3% against 15% for network solutions, and that the company has disclosed periods of declining patient-management referrals tied to competition, office consolidation and staff turnover. They also flag that the moat depends on technology that the filing itself says may become obsolete and require costly replacement, that new AI-based entrants could change claims processes and pricing, and that a business handling sensitive claimant health data carries cyber and regulatory exposure the company describes as potentially material.

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

Sedgwick Claims Management Services, Inc.Not tracked

The largest US third-party administrator of workers' compensation and liability claims, bidding for the same self-insured employers and carriers CorVel serves, with the same bundled claims-plus-managed-care offering.

Gallagher Bassett Services, Inc.Not tracked

The claims-administration arm of Arthur J. Gallagher & Co., it handles workers' compensation and general liability claims for US corporate and public-entity risk pools — the same accounts CorVel competes for.

Crawford & Company (Broadspire)CRD-A

Through its Broadspire division Crawford sells third-party claims administration and medical management to US employers and insurers, overlapping directly with CorVel's patient-management business.

Enlyte (Mitchell | Genex | Coventry)Not tracked

Enlyte competes head-on with CorVel's Network Solutions segment, selling medical bill review, PPO networks, pharmacy benefit management and case management to workers' compensation payers.

ESIS, Inc.Not tracked

Chubb's in-house third-party administrator handles workers' compensation and liability claims plus medical cost containment for large self-insured US employers, the core CorVel customer.

资产负债表与流动性

营收

$984M

最近12个月(截至2026/6/30)

净利润

$115M

最近12个月(截至2026/6/30)

自由现金流

$110M

股东权益合计

$394M

负债合计

$249M

流动比率

1.94

利息覆盖率

-

债务/EBITDA

0.15

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形被高估

公允价值

$26.46

当前价格

$75.69

安全边际

-186.1%

公允价值区间

$21.99 - $30.93

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:数据不足,无法计算
现金流折现法(DCF):$27.07
市盈率法(P/E):$30.46
格雷厄姆成长公式:$16.83
盈利能力价值(EPV):$22.25
合理市净率(P/B):$26.41
股息折现模型(戈登模型):数据不足,无法计算
P/FFO(运营资金):$45.01
周期中段收益:数据不足,无法计算
市销率法(P/S):$50.54

估值指标

市盈率(P/E)

33.13

ROE

28.0%

市净率(P/B)

9.21

P/FCF

33.09

毛利率

24.8%

ROIC

-

盈利能力雷达图

价值创造(经济护城河)

ROIC

-

WACC

10.5%

ROIC − WACC

-

基本面分析标准

通过(14)

  • EPS shows upward trend
  • Price CAGR 19.64%
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 29.9%
  • Revenue Growth 5Y 11.6%
  • Earnings Quality (OCF/NI) 1.31
  • Share Dilution -0.8%
  • Net Margin Trend 11.7% vs 11.0%
  • Piotroski F-Score 7/9

未通过(7)

  • EPS CAGR 0.24%
  • Gross Margin 24.8%
  • P/FCF 33.09
  • P/B Ratio 9.21
  • CapEx intensity
  • Price below Graham Number
  • DCF valuation (Overvalued)

不可用(7)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Analyst Consensus (Finnhub)
  • Earnings Surprise (no valid data)
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-评分

7/9

财务状况强健

score
criteria

盈利质量

1.31

高质量:盈利有现金流支撑

股权稀释

-0.8%

正在回购股份,对股东友好

机构持股

公司治理

管理团队

姓名职位年龄
Mr. Michael G. CombsExecutive Chair61
Mr. Brian S. NicholsChief Financial Officer44
Ms. Jennifer L. YossVice President of Accounting47
Mr. Maxim ShishinChief Information Officer50
Mr. Mark E. BertelsExecutive Vice President of Risk Management Services62
Ms. Sarah ScottPresident & CEO48
Ms. Sharon F. O'ConnorVice President of Legal Services-
Melissa StoranVice President of Marketing-
Jason WheelerVice President of Sales & Account Management-
Mr. Jeffrey D. GurtcheffChief Claims Officer-

审计风险

4

董事会风险

7

薪酬风险

5

股东权利风险

7

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-05-22

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-08-06

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-08-11

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for CRVL, sourced from Markets Gazette.

No recent news for CRVL.